Literature DB >> 11823543

Anti-sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens.

Micah T McClain1, Paul A Ramsland, Kenneth M Kaufman, Judith A James.   

Abstract

Autoantibodies directed against spliceosomal proteins are a common and specific feature of systemic lupus erythematosus. These autoantibodies target a collection of proteins, including Sm B, B', D1, D2, and D3. We define the common antigenic targets of Sm D2 and D3 and examine their role in spliceosomal autoimmunity. Our results define nine major common epitopes, five on Sm D2 and four on Sm D3. These epitopes have significantly higher (more basic) isoelectric points than do nonantigenic regions. In fact, this association is of sufficient power to make isoelectric point an excellent predictor of spliceosomal antigenicity. The crystallographic structure of Sm D2 and D3 is now partially described. The anti-Sm D2 and D3 antigenic targets are located on the surface of the respective three-dimensional complexed proteins, thereby suggesting that these epitopes are accessible in the native configuration. All but one of these nine epitopes conspicuously avoid the specific regions involved in intermolecular interactions within the spliceosomal complex. One of the D3 epitopes (RGRGRGMGR) has significant sequence homology with a major antigenic region of Sm D1 (containing a carboxyl-terminal glycine-arginine repeat), and anti-D3 Abs cross-react with this epitope of Sm D1. These results demonstrate that spliceosomal targets of autoimmunity are accessible on native structure surfaces and that cross-reactive epitopes, as well as structural associations of various spliceosomal Ags, may be involved in the induction of autoimmunity in systemic lupus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823543     DOI: 10.4049/jimmunol.168.4.2054

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.

Authors:  Lauren L Ritterhouse; Sherry R Crowe; Timothy B Niewold; Joan T Merrill; Virginia C Roberts; Amy B Dedeke; Barbara R Neas; Linda F Thompson; Joel M Guthridge; Judith A James
Journal:  Arthritis Rheum       Date:  2011-12

2.  Anti-neutrophil cytoplasmic antibodies target sequential functional proteinase 3 epitopes in the sera of patients with Wegener’s granulomatosis.

Authors:  B F Bruner; E S Vista; D M Wynn; J B Harley; J A James
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

3.  The binding of lupus-derived autoantibodies to the C-terminal peptide (83-119) of the major SmD1 autoantigen can be mediated by double-stranded DNA and nucleosomes.

Authors:  J W Dieker; C C Van Bavel; G Riemekasten; J H Berden; J van der Vlag
Journal:  Ann Rheum Dis       Date:  2006-03-15       Impact factor: 19.103

4.  Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease.

Authors:  J A Somarelli; A Mesa; R Rodriguez; R Avellan; L Martinez; Y J Zang; E L Greidinger; R J Herrera
Journal:  Lupus       Date:  2011-03       Impact factor: 2.911

5.  Improved serological differentiation between systemic lupus erythematosus and mixed connective tissue disease by use of an SmD3 peptide-based immunoassay.

Authors:  M Mahler; L M Stinton; M J Fritzler
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

6.  60 kD Ro and nRNP A frequently initiate human lupus autoimmunity.

Authors:  Latisha D Heinlen; Micah T McClain; Lauren L Ritterhouse; Benjamin F Bruner; Colin C Edgerton; Michael P Keith; Judith A James; John B Harley
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

7.  Profiling humoral immune responses to P. falciparum infection with protein microarrays.

Authors:  Denise L Doolan; Yunxiang Mu; Berkay Unal; Suman Sundaresh; Siddiqua Hirst; Conrad Valdez; Arlo Randall; Douglas Molina; Xiaowu Liang; Daniel A Freilich; J Aggrey Oloo; Peter L Blair; Joao C Aguiar; Pierre Baldi; D Huw Davies; Philip L Felgner
Journal:  Proteomics       Date:  2008-11       Impact factor: 3.984

8.  Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus.

Authors:  Brian D Poole; Rebecca I Schneider; Joel M Guthridge; Cathy A Velte; Morris Reichlin; John B Harley; Judith A James
Journal:  Arthritis Rheum       Date:  2009-03

9.  Aberrant Epstein-Barr viral infection in systemic lupus erythematosus.

Authors:  Brian D Poole; Amanda K Templeton; Joel M Guthridge; Eric J Brown; John B Harley; Judith A James
Journal:  Autoimmun Rev       Date:  2009-01-22       Impact factor: 9.754

10.  Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response.

Authors:  Micah T McClain; Carol S Lutz; Kenneth M Kaufman; Ofer Z Faig; Timothy F Gross; Judith A James
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.